Lymphoblastosis Benign Acute

Lymphoblastic disease is an infectious disease that develops in the human body in response to infected viruses. The lymphatic system interacts with the virus and begins to produce antibodies to fight the infection, but dormant antibodies can cause illness.

Lymphoblastic blastomyelosis is one of the first neoplasms of the hematological profile (tumor diseases of the circulatory system). Of the total number of leukemias, lymphoblastic forms about 56%. This diagnosis is blastic leukemia, in which bone marrow lymphocytes have transformed. This disease is characterized by a course without remission. This leads to the rule of prognosis for blastic leukemia - the amount of time the patient survives depends on the degree of unfavorability of the body in relation to the lesion. If this degree of manifestation is high, then the survival rate is only a few weeks, and if it is low, then it is several years.

**Lymphoblastic leukemia** is a malignant tumor of the lymphatic system in the form of the formation of numerous tumor cells that have undergone blast metamorphosis during their evolution. The origin of lymphoblastic leukemia cells is also lymphoid. The cellular substrate of this process usually originates from the precursors of lymph nodes and bone marrow tissue. Depending on the duration of the disease, acute, subacute, chronic and recurrent (recurrent) lymphoblastic leukemia are distinguished. All types of leukemia are characterized by a rapid course of the disease and high mortality of patients. To estimate the total incidence of morbidity and mortality in these forms, units such as “the number of diseases per 1 million population” and “the number of patients per 1 thousand population” are used.

With a full examination of all patients suffering from acute lymphocytic leukemia, it can be established that almost everyone had one or two precursors of the disease. Precursors can be varied - pain of various localizations, colds, malaise. In preschool children, the first signs of the disease are usually a long-lasting high temperature, swollen lymph nodes, weight loss, hemorrhages on the skin of the face and torso, bloody skin rashes, and night sweats. With timely and complete treatment, most manifestations of acute leukemic syndrome are eliminated within 4-8 weeks. The remaining underlying disease progresses more slowly. If during the first 6 months it is not possible to adequately treat chronic leukemia, then the second phase of the disease begins - the metastasis phase, when dissemination of tumor clones into internal organs occurs.

Number of diseases per 20,000